Meinrad Gawaz mainly investigates Platelet, Internal medicine, Immunology, Cardiology and Platelet activation. The study incorporates disciplines such as Endothelium, Cell adhesion and Cell biology in addition to Platelet. His research integrates issues of Anesthesia and Surgery in his study of Internal medicine.
His research in Immunology intersects with topics in Vascular disease, Pathophysiology and Pharmacology. His work is dedicated to discovering how Cardiology, Coronary stent are connected with Partial thromboplastin time and other disciplines. In Platelet activation, Meinrad Gawaz works on issues like Stroke, which are connected to Ischemia.
His primary areas of study are Internal medicine, Cardiology, Platelet, Platelet activation and Cell biology. As part of his studies on Internal medicine, he frequently links adjacent subjects like Endocrinology. His work in the fields of Cardiology, such as Percutaneous coronary intervention, Conventional PCI and Heart failure, overlaps with other areas such as In patient.
His Platelet study results in a more complete grasp of Immunology. His studies in Platelet activation integrate themes in fields like Molecular biology, Biochemistry and Thrombin. His Cell biology research integrates issues from Endothelial stem cell and Cell adhesion.
Meinrad Gawaz mostly deals with Internal medicine, Cardiology, Platelet, Myocardial infarction and Coronary artery disease. His work focuses on many connections between Internal medicine and other disciplines, such as Gastroenterology, that overlap with his field of interest in Monocyte. He studies Platelet, namely Platelet activation.
The concepts of his Platelet activation study are interwoven with issues in Thrombin, Lipidomics and Cell biology. His study looks at the relationship between Myocardial infarction and topics such as Ejection fraction, which overlap with Cardiomyopathy and Myocarditis. His Coronary artery disease study combines topics from a wide range of disciplines, such as Ischemia and Respiratory failure.
His scientific interests lie mostly in Internal medicine, Platelet, Cardiology, Platelet activation and Myocardial infarction. Many of his studies involve connections with topics such as Endocrinology and Internal medicine. His biological study spans a wide range of topics, including Rivaroxaban, Receptor, Thrombosis, Thrombus and Antibody.
His study in the field of Mitral regurgitation also crosses realms of In patient. Meinrad Gawaz has researched Platelet activation in several fields, including Cancer research, Lipidomics, Cytoskeleton, Cell biology and Cofilin. He interconnects Endocardium, Ex vivo, Artery and Necrosis in the investigation of issues within Myocardial infarction.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Platelets in inflammation and atherogenesis
Meinrad Gawaz;Harald Langer;Andreas E. May.
Journal of Clinical Investigation (2005)
A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation
Steffen Massberg;Korbinian Brand;Sabine Grüner;Sharon Page.
Journal of Experimental Medicine (2002)
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White.
The New England Journal of Medicine (2012)
Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement.
Iris Müller;Felicitas Besta;Christian Schulz;Steffen Massberg.
Thrombosis and Haemostasis (2003)
A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study.
Dietmar Trenk;Gregg W. Stone;Meinrad Gawaz;Adnan Kastrati.
Journal of the American College of Cardiology (2012)
Effect of Glycoprotein IIb/IIIa Receptor Blockade on Recovery of Coronary Flow and Left Ventricular Function After the Placement of Coronary-Artery Stents in Acute Myocardial Infarction
Franz-Josef Neumann;Rudolf Blasini;Claus Schmitt;Eckhard Alt.
A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo
Steffen Massberg;Meinrad Gawaz;Sabine Grüner;Valerie Schulte.
Journal of Experimental Medicine (2003)
Cardiac Release of Cytokines and Inflammatory Responses in Acute Myocardial Infarction
Franz-Josef Neumann;Ilka Ott;Meinrad Gawaz;Gert Richardt.
Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation
Tobias Geisler;Harald Langer;Magdalena Wydymus;Katrin Göhring.
European Heart Journal (2006)
A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.
Adnan Kastrati;Julinda Mehilli;Helmut Schühlen;Josef Dirschinger.
The New England Journal of Medicine (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: